|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.91 SEK | -5.52% |
|
-15.65% | -26.24% |
| Apr. 25 | Enzymatica AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 27 | Enzymatica AB Announces Composition of Nomination Committee | CI |
Enzymatica AB (publ) reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was SEK 13.04 million compared to SEK 4.16 million a year ago. Net loss was SEK 14.92 million compared to SEK 18.05 million a year ago.
Basic loss per share from continuing operations was SEK 0.09 compared to SEK 0.12 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -26.24% | 48.71M | |
| +26.47% | 661B | |
| +26.74% | 566B | |
| -6.33% | 352B | |
| +19.35% | 332B | |
| +4.23% | 283B | |
| +13.43% | 231B | |
| +4.71% | 200B | |
| -9.53% | 195B | |
| -4.04% | 145B |
ENZYMATICA AB 
